OPKO Health Share Holder Equity 2010-2024 | OPK
OPKO Health Annual Share Holder Equity (Millions of US $) |
|
---|---|
2023 | $1,389 |
2022 | $1,562 |
2021 | $1,685 |
2020 | $1,672 |
2019 | $1,615 |
2018 | $1,791 |
2017 | $1,844 |
2016 | $2,092 |
2015 | $1,980 |
2014 | $836 |
2013 | $873 |
2012 | $179 |
2011 | $161 |
2010 | $23 |
2009 | $32 |
OPKO Health Quarterly Share Holder Equity (Millions of US $) |
|
---|---|
2024-09-30 | $1,403 |
2024-06-30 | $1,395 |
2024-03-31 | $1,253 |
2023-12-31 | $1,389 |
2023-09-30 | $1,445 |
2023-06-30 | $1,535 |
2023-03-31 | $1,552 |
2022-12-31 | $1,562 |
2022-09-30 | $1,629 |
2022-06-30 | $1,719 |
2022-03-31 | $1,615 |
2021-12-31 | $1,685 |
2021-09-30 | $1,766 |
2021-06-30 | $1,743 |
2021-03-31 | $1,697 |
2020-12-31 | $1,672 |
2020-09-30 | $1,624 |
2020-06-30 | $1,588 |
2020-03-31 | $1,549 |
2019-12-31 | $1,615 |
2019-09-30 | $1,642 |
2019-06-30 | $1,709 |
2019-03-31 | $1,763 |
2018-12-31 | $1,791 |
2018-09-30 | $1,789 |
2018-06-30 | $1,810 |
2018-03-31 | $1,823 |
2017-12-31 | $1,844 |
2017-09-30 | $2,089 |
2017-06-30 | $2,107 |
2017-03-31 | $2,107 |
2016-12-31 | $2,092 |
2016-09-30 | $2,105 |
2016-06-30 | $2,016 |
2016-03-31 | $1,998 |
2015-12-31 | $1,980 |
2015-09-30 | $1,969 |
2015-06-30 | $827 |
2015-03-31 | $813 |
2014-12-31 | $836 |
2014-09-30 | $887 |
2014-06-30 | $913 |
2014-03-31 | $831 |
2013-12-31 | $873 |
2013-09-30 | $868 |
2013-06-30 | $312 |
2013-03-31 | $320 |
2012-12-31 | $179 |
2012-09-30 | $146 |
2012-06-30 | $152 |
2012-03-31 | $155 |
2011-12-31 | $161 |
2011-09-30 | $102 |
2011-06-30 | $111 |
2011-03-31 | $124 |
2010-12-31 | $23 |
2010-09-30 | $20 |
2010-06-30 | $50 |
2010-03-31 | $56 |
2009-12-31 | $32 |
2009-09-30 | $64 |
2009-06-30 | $39 |
2009-03-31 | $-8 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $1.051B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $200.449B | 24.45 |
Intuitive Surgical (ISRG) | United States | $186.791B | 97.66 |
Edwards Lifesciences (EW) | United States | $44.123B | 28.02 |
Alcon (ALC) | Switzerland | $41.807B | 27.97 |
IQVIA Holdings (IQV) | United States | $35.805B | 19.73 |
IDEXX Laboratories (IDXX) | United States | $33.758B | 39.76 |
DexCom (DXCM) | United States | $31.263B | 47.08 |
Waters (WAT) | United States | $21.860B | 32.32 |
STERIS (STE) | Ireland | $20.481B | 23.58 |
SONOVA HOLDING (SONVY) | Switzerland | $19.736B | 0.00 |
Hologic (HOLX) | United States | $16.260B | 17.56 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $13.386B | 13.74 |
Sysmex ADR (SSMXY) | Japan | $11.751B | 0.00 |
Globus Medical (GMED) | United States | $11.252B | 28.49 |
Penumbra (PEN) | United States | $9.308B | 91.18 |
Masimo (MASI) | United States | $9.076B | 43.92 |
Glaukos (GKOS) | United States | $8.319B | 0.00 |
Teleflex (TFX) | United States | $8.274B | 13.20 |
Integer Holdings (ITGR) | United States | $4.484B | 25.41 |
PROCEPT BioRobotics (PRCT) | United States | $4.236B | 0.00 |
Inari Medical (NARI) | United States | $3.246B | 0.00 |
Veracyte (VCYT) | United States | $3.169B | 95.09 |
LivaNova (LIVN) | United Kingdom | $2.584B | 14.92 |
Nihon Kohden (NHNKY) | Japan | $2.392B | 18.17 |
Tandem Diabetes Care (TNDM) | United States | $2.358B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.084B | 18.74 |
TransMedics (TMDX) | United States | $2.071B | 65.64 |
Integra LifeSciences Holdings (IART) | United States | $1.682B | 8.79 |
RxSight (RXST) | United States | $1.357B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.326B | 0.00 |
Artivion (AORT) | United States | $1.194B | 79.11 |
Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
Paragon 28 (FNA) | United States | $0.840B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.739B | 12.56 |
Mesa Laboratories (MLAB) | United States | $0.717B | 16.91 |
IRadimed (IRMD) | United States | $0.693B | 37.43 |
AxoGen (AXGN) | United States | $0.688B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
Semler Scientific (SMLR) | United States | $0.573B | 30.14 |
SiBone (SIBN) | United States | $0.556B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.434B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.408B | 22.08 |
AngioDynamics (ANGO) | United States | $0.361B | 0.00 |
Delcath Systems (DCTH) | United States | $0.352B | 0.00 |
NeuroPace (NPCE) | United States | $0.344B | 0.00 |
CVRx (CVRX) | United States | $0.294B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
Inogen (INGN) | United States | $0.202B | 0.00 |
Accuray (ARAY) | United States | $0.186B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.184B | 0.00 |
Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
Nevro (NVRO) | United States | $0.142B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
Spectral Diagnostics (EDTXF) | Canada | $0.091B | 0.00 |
LENSAR (LNSR) | United States | $0.089B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
InspireMD (NSPR) | Israel | $0.078B | 0.00 |
908 Devices (MASS) | United States | $0.072B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
Hyperfine (HYPR) | United States | $0.065B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.061B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
Neuronetics (STIM) | United States | $0.042B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
Spectral AI (MDAI) | United States | $0.035B | 0.00 |
Envoy Medical (COCH) | United States | $0.033B | 0.00 |
Precision Optics (POCI) | United States | $0.033B | 0.00 |
NexGel (NXGL) | United States | $0.032B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.029B | 0.00 |
DarioHealth (DRIO) | United States | $0.027B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.023B | 0.00 |
Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
PAVmed (PAVM) | United States | $0.006B | 0.00 |
Tenon Medical (TNON) | United States | $0.006B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
Nuwellis (NUWE) | United States | $0.004B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |